Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma
about
Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002.Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses.Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
P2860
Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of Repeat Dosing of Eng ...... cal Models of Rhabdomyosarcoma
@en
Effect of Repeat Dosing of Eng ...... al Models of Rhabdomyosarcoma.
@nl
type
label
Effect of Repeat Dosing of Eng ...... cal Models of Rhabdomyosarcoma
@en
Effect of Repeat Dosing of Eng ...... al Models of Rhabdomyosarcoma.
@nl
prefLabel
Effect of Repeat Dosing of Eng ...... cal Models of Rhabdomyosarcoma
@en
Effect of Repeat Dosing of Eng ...... al Models of Rhabdomyosarcoma.
@nl
P2093
P2860
P1476
Effect of Repeat Dosing of Eng ...... cal Models of Rhabdomyosarcoma
@en
P2093
Alicia M Waters
Elizabeth A Beierle
Evan F Garner
G Yancey Gillespie
James M Markert
Jennifer M Coleman
Jerry E Stewart
Laura L Stafman
Smitha Mruthyunjayappa
P2860
P304
P356
10.1016/J.TRANON.2016.07.008
P577
2016-10-01T00:00:00Z